First human tests begin for experimental drug CIT-013
NCT ID NCT07499908
Summary
This early-stage study aims to check the safety and how the body processes CIT-013, an experimental drug given by injection. It will involve 10 healthy adults who will receive either the drug or a placebo. The main goal is to see what side effects occur and how the drug moves through the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
ICON
Groningen, Netherlands
Contact
Conditions
Explore the condition pages connected to this study.